Benzinga | Sep 28, 2021 07:43AM EDT

'$SAVA Yale was removed as a participating enrollment center for the company's simufilam REFOCUS-ALZ Phase 3 study.' -STAT Reporter

https://twitter.com/adamfeuerstein/status/1442815799618584576